EM

Eric Moessinger

Partner at NanoDimension

Redwood City, California

Overview

Work Experience

N

NanoDimension

  • Partner

    2008 - Current

    NanoDimension is a venture capital firm investing in disruptive technologies at the convergence of the life, physical and data sciences. Focus on life science related investments at +ND. Joined in 2008 as the first employee of +ND’s Bay Area office. Currently serve on the board of directors of Emulate, Visby, Serotiny, Partillion and AIRNA, and observe on the boards of Inscripta, Lightcast and IonPath. Previously served as a board member at Icosavax (Nasdaq: ICVX) and SQZ (NYSE: SQZ), and observed on the board of ARMO (acquired by Lilly) and Twist (Nasdaq: TWST). Helped lead +ND’s investments in Orca and Octant.

B&

Bain & Company

  • Senior Associate Consultant

    2005 - 2008

Education

Investments

Partillion Bioscience

Seed

Total Funding: $5M

SQZ Biotech

Series B

Total Funding: $160M

Inscripta

Series B

Total Funding: $260M

Serotiny

Seed

Total Funding: $3M

Relevant Websites